A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion

Virology

Volumn 238, Issue 2, 1997, Pages 283-290

  Bagai, Sangeeta ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; FLUORESCENT DYE; GLYCINE; MUTANT PROTEIN; OCTADECYLAMINE; RHODAMINE; RNA POLYMERASE; VIRUS FUSION PROTEIN; VIRUS VECTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BACTERIOPHAGE T7; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SYNCYTIUM; VACCINIA VIRUS; VIRUS RECOMBINANT;

EID: 0031585569     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8858     Document Type: Article

References (43)

1. Asano K., Asano A. Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes? Biochem. Int. 10:1985;115-122.
2. Bagai S., Lamb R. A. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:1995;6712-6719.
3. Bagai S., Lamb R. A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:1996;73-84.
4. Bagai S., Puri A., Blumenthal R., Sarkar D. P. Hemagglutinin-neuraminidase enhances F protein-mediated membrane fusion of reconstituted Sendai virus envelopes with cells. J. Virol. 67:1993;3312-3318.
5. Bosch M. L., Earl P. L., Fargndi K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. Identifications of the fusion peptide of primate immunodeficiency viruses. Science. 244:1989;694-696.
6. Brasseur R., Lorge P., Goormaghtigh E., Ruysschaert J.-M., Espion D., Burny A. The mode of insertion of the paramyxovirus F1 N-terminus into lipid matrix, and initial step in host cell/virus fusion. Virus Genes. 4:1988;325-332.
7. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
8. 7. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
9. Gething M.-J., White J. M., Waterfield M. D. Purification of the fusion protein of Sendai virus: Analysis of the NH2-terminal sequence generated during precursor activation. Proc. Natl. Acad. Sci. USA. 75:1978;2737-2740.
10. Harter C., Bachi T., Semenza B., Brunner J. Hydrophobic photolabeling identifies BHA2 as the subunit mediating the interaction of bromelain-solubilized influenza virus hemagglutinin with liposomes at low pH. Biochemistry. 27:1988;1856-1864.
11. Hoekstra D., de Boer T., Klappe K., Wilschut J. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry. 23:1984;5675-5681.
12. Horth M., Lambrecht B., Kim M. C.-L., Bex F., Thiriart C., Ruysschaert J. M., Burny A., Brasseur R. Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:1991;2747-2755.
13. Horvath C. M., Lamb R. A. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion. J. Virol. 66:1992;2443-2455.
14. Horvath C. M., Paterson R. G., Shaughnessy M. A., Wood R., Lamb R. A. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 66:1992;4564-4569.
15. Hsu M.-C., Scheid A., Choppin P. W. Activation of the Sendai virus fusion protein (F) involved a conformational change with exposure of a new hydrophobic region. J. Biol. Chem. 156:1981;3557-3563.
16. Kemble G. W., Danieli T., White J. M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76:1994;383-391.
17. Klenk H.-D., Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:1994;39-43.
18. Lamb R. A. Paramyxovirus fusion: A hypothesis for change. Virology. 197:1993;1-11.
19. Lamb R. A., Choppin P. W. Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology. 74:1976;504-519.
20. Lamb R. A., Etkind P. R., Choppin P. W. Evidence for a ninth influenza viral polypeptide. Virology. 91:1978;60-78.
21. Martin I., Schaal H., Scheid A., Ruysschaert J.-M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70:1996;298-304.
22. Morris S. J., Sarkar D. P., White J. M., Blumenthal R. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. J. Biol. Chem. 264:1989;3972-3978.
23. Morrison T., Portner A. Structure, function, and intracellular processing of the glycoproteins ofParamyxoviridae. The Paramyxoviruses. 1991;Plenum, New York. p. 347-382.
24. Novick S. L., Hoekstra D. Membrane penetration of Sendai virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling. Proc. Natl. Acad. Sci. USA. 85:1988;7433-7437.
25. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus- based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
26. Paterson R. G., Harris T. J. R., Lamb R. A. Fusion protein of the paramyxovirus simian virus 5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. USA. 81:1984;6706-6710.
27. Paterson R. G., Hiebert S. W., Lamb R. A. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc. Natl. Acad. Sci. USA. 82:1985;7520-7524.
28. Paterson R. G., Lamb R. A. Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor. Cell. 48:1987;441-452.
29. Paterson R. G., Lamb R. A. The molecular biology of influenza viruses and paramyxoviruses. Davidson A., Elliott R. M. Molecular Virology: A Practical Approach. 1993;35-73 IRL Oxford Univ. Press, Oxford.
30. Randall R. E., Young D. F., Goswami K. K. A., Russell W. C. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68:1987;2769-2780.
31. Reitter J. N., Sergel T., Morrison T. G. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:1995;5995-6004.
32. Richardson C. D., Choppin P. W. Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: Studies on the site of action. Virology. 131:1983;518-532.
33. 12. Virology. 105:1980;205-222.
34. Rose J. K., Buonocore L., Whitt M. A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechnology. 10:1991;520-525.
35. Sarkar D. P., Morris S. J., Eidelman O., Zimmerberg J., Blumenthal R. Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: Cytoplasmic continuity and lipid mixing. J. Cell Biol. 109:1989;113-122.
36. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 57:1974;475-490.
37. Scheid A., Graves M., Silver S., Choppin P. W. Studies on the structure and function of paramyxovirus glycoproteins. Mahy B. W. J., Barry R. D. Negative Strand Viruses and the Host Cell. 1978;181-193 Academic Press, London.
38. Sergel T., McGinnes L. W., Peeples M. E., Morrison T. G. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 193:1993;717-726.
39. Simpson D. A., Lamb R. A. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J. Virol. 66:1992;790-803.
40. Steinhauer D. A., Wharton S. A., Skehel J. J., Wiley D. C. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J. Virol. 69:1995;6643-6651.
41. Strehlow K. G., Baldwin R. L. Effect of the substitution Ala-Gly at each of five residue positions in the C-peptide helix. Biochemistry. 28:1989;2130-2133.
42. von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur. J. Biochem. 133:1983;17-21.
43. Vonèche V., Portetelle D., Kettmann R., Willems L., Limbach K., Paoletti E., Ruysschaert J. M., Burny A., Brasseur R. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. USA. 89:1992;3810-3814.